trending Market Intelligence /marketintelligence/en/news-insights/trending/ziwb7sfsuo6oi1_riq0g2a2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Court denies activist investor's injunction against Humana, Kindred deal

Infrastructure Issues: Tools to Dig Deep on Potential Risks

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

Part Two IFRS 9 Blog Series: The Need to Upgrade Analytical Tools


Court denies activist investor's injunction against Humana, Kindred deal

Kindred Healthcare Inc. said a U.S. state court denied a motion to halt the $4.1 billion acquisition of the company by Humana Inc. and two private equity firms.

The motion was filed by activist investor Brigade Capital Management, which owns 5.8% of Kindred, in the Court of Chancery of the State of Delaware.

Brigade Capital opposed the deal, saying it "severely undervalues" the medical facility operator.

Kindred shareholders will vote on the transaction, which priced the company's common shares at $9 each, on March 29. The polls will close April 5.